Browsing: eczema

Recognising and understanding childhood conditions can help in managing them effectively. Dr Mohana, a paediatrician with a subspecialty in paediatric allergy and immunology, recently discussed some of the most prevalent childhood conditions during the early years of life in a YouTube video on our channel, shedding light on how parents can navigate these challenges.

Eczema, or atopic dermatitis, is a chronic, relapsing, inflammatory skin condition characterised by the development of intense eczematous lesions and severe itching. This condition results in significant discomfort and distress to sufferers. Typically, eczema develops in childhood and in approximately 80% of children with eczema, the disease persists into adulthood. In higher-income countries, rapid urbanisation has led to the disease affecting around 20% of children and up to 10% of adults. Globally, eczema impacts around 194.4 million people. Alarmingly, the prevalence of eczema is increasing worldwide, including in large parts of Asia. In Southeast Asia alone, between 3.7- 13.5% of children aged 6-7 years old suffer from eczema. It becomes crucial to understand the factors contributing to eczema and how to manage it effectively.

Log In or Register as a healthcare professional to read the full article.

Galderma, a global dermatology company, has received filing acceptances for its breakthrough treatment nemolizumab. The drug is designed to treat prurigo nodularis and moderate-to-severe atopic dermatitis in adolescents and adults. It received regulatory nods from authorities in Australia, Singapore, Switzerland, and the United Kingdom via the Access Consortium framework.

Log In or Register as a healthcare professional to read the full article.

Medical Channel Asia presents the weekly Asian medical news bulletin, bringing you essential healthcare news from across the region. This week’s bulletin covers HIV cases in the Philippines, illegal eczema creams in Singapore and more.